Company intelligence / Profile preview
Elastrin Therapeutics
Greenville, South Carolina, United Stateselastrin.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Elastrin’s lead program uses EDTA-loaded nanoparticles conjugated with a proprietary monoclonal antibody to target and remove pathological calcification from sites of degraded elastin. The company has demonstrated preclinical efficacy in reversing vascular calcification, with plans to enter clinical trials in the near future. Their technology aims not only to halt but also reverse age-related cardiovascular disease by restoring tissue elasticity
- Therapeutic areas
- PulmonologyCardiovascular
- Modalities
- Nanoparticle drug deliveryMonoclonal antibodies (proprietary antibody-conjugated nanoparticles)Small molecules (EDTA as a chelating agent)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Ongoing onboarding of medical and biotech partners; specific names not disclosed
Beyond the preview
Go deeper on Elastrin Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elastrin Therapeutics.